Real-life GOLD 2011 implementation: The management of COPD lacks correct classification and adequate treatment

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Koblizek, Vladimir ^a   Pecen, Ladislav ^b   Zatloukal, Jaromir ^c   Kocianova, Jana ^d   Plutinsky, Marek ^e   Kolek, Vitezslav ^c   Novotna, Barbora ^a   Kocova, Eva ^a   Pracharova, Sarka ^a   Tichopad, Ales ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CEEOR Institute   (Czech Republic)

^c UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^d Chest Clinic   (Czech Republic)

^e UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; CZECH (CITIZEN); DIAGNOSTIC ERROR; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DRUG INDICATION; DRUG USE; FEMALE; HEALTH CARE QUALITY; HUMAN; INAPPROPRIATE PRESCRIBING; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRACTICE GUIDELINE; PULMONOLOGIST; QUESTIONNAIRE; SYMPTOMATOLOGY; CLASSIFICATION; CZECH REPUBLIC; MEDICINE; PATIENT CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICS AND NUMERICAL DATA;

AGED; CZECH REPUBLIC; FEMALE; HUMANS; MALE; MEDICINE; PATIENT CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84915747236     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111078     Document Type: Article

References (43)

1. Caballero A, Torres-Duque CA, Jaramillo C, Bolívar F, Sanabria F, et al. (2008) Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest 133(2): 343-349.
2. Buist SA, Vollmer WM, McBurnie (2008) Worldwide burden of COPD in highand low-income countries. Part I. The burden of obstructive lung disease (BOLD). Int J Tuberc Lung Dis 12(7): 703-708.
3. Bridevaux PO, Probst-Hensch NM, Schindler C, Curjuric I, Felber Dietrich D, et al. (2010) Prevalence of airflow obstruction in smokers and never-smokers in Switzerland. Eur Respir J 36(6): 1259-1269.
4. Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442.
5. World Health Organization. Burden of COPD. Available: http://www.who.int/respiratory/copd/burden/en/. Accessed 5 June 2013.
6. World Health Organization WHO Europe detailed mortality datafiles. Available: http://www.euro.who.int/en/what-we-do/data-and-evidence/databases/european-detailed-mortality-database-dmdb2. Accessed 1 April 2012.
7. Poznańska A, Wojtyniak B, Seroka W (2011) Main causes of death among Polish population in 2030. Przegl Epidemiol 65(3): 483-489.
8. Maly M, Zvolsky M, Rozborilova E, Vondra V (2013) Respiratory Mortality in Czech and Slovak Republics in the year 2011. Stud pneumol et phtiseol 73(4): 128-132.
9. Decramer M, Brusselle G, Buffels J, Corhay JL, De Backer W, et al. (2013) COPD awareness survey: do Belgian pulmonary physicians comply with the GOLD guidelines 2010? Acta Clin Belg 68(5): 325-340.
10. Bellamy D, Bouchard J, Henrichsen S, Johansson G, Langhammer A, et al. (2006) International Primary Care Respiratory Group (IPCRG) Guidelines: management of chronic obstructive pulmonary disease (COPD). Prim Care Respir J 15(1): 48-57.
11. Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, et al. (2011) Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update for the ACP, ACCP, ATS and ERS. Ann Intern Med 155(3): 179-191.
12. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Updated 2013. Available: http://www.goldcopd.org/uploads/users/files/GOLD-Report-2013-Feb20.pdf Accessed 3 March 2013.
13. O'Donnell DE, Aaron S, Bourbeau J, Hernandez P, Marciniuk DD, et al. (2007) Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J 14 Suppl B: 5B-32B.
14. National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease (updated) Clinical guidelines CG101. Available: http://www.nice.org.uk/CG101 Accessed: 2 April 2013.
15. Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, et al. (2014) Spanish Guideline for COPD (GesEPOC). Arch Bronchoconeumol; 50 Suppl 1: 1-16.
16. Gupta D, Agarwal R, Aggarwal AN, Maturu VN, Dhooria S, et al. (2013) Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations. Lung India 30(3): 228-67.
17. Koblizek V, Chlumsky J, Zindr V, Neumannova K, Zatloukal J, et al. (2013) Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 157(2): 189-201.
18. Glaab T, Vogelmeier C, Hellmann A, Buhl R (2012) Guideline-based survey of outpatient COPD management by pulmonary specialist in Germany. Int J Chron Obstruct Pulmon Dis 7: 101-8.
19. Glaab T, Banik N, Rutschmann OT, Wencler M (2006) National survey of guideline-compliant COPD management among pneumologist and primary care physicians. Int J Chron Obstruct Pulmon Dis 3(3): 141-148.
20. Desalu OO, Onyedum CC, Adeoti AO, Gundiri LB, Fadare JO, et al. (2013) Guideline-based COPD management in a resource-limited setting - physicians' understanding, adherence and barriers: a cross-sectional survey of internal and family medicine hospital-based physicians in Nigeria. Prim Care Respir J 22(1): 79-85.
21. Montanari U, Quadrelli D, Donato G, Mercuri M, Scorletti A, et al. (2013) Implementation of diagnostic accuracy for COPD (ABC Project): evaluation of a guide-line in territorial clinical practice. Recenti Prog Med 104(1): 23-7.
22. Sarc I, Jeric T, Ziherl K, Suskovic S, Kosnik M, et al. (2011) Adherence to treatment quidelines and long-term survival in hospitalized patients with chronic obstructive pulmonary disease. J Eval Clin Pract 17(4): 737-43.
23. Miravitlles M, Brosa M, Velasco M, Crespo C, Gobartt E, et al. (2009) An economic analysis of pharmacological treatment of COPD in Spain. Resp Med 103(5): 714-721.
24. Vestbo J, Vogelmeier C, Small M, Higgins V (2014) Understanding the GOLD 2011 Strategy as applied to a real-world COPD population. Respir Med 108(5): 729-36.
25. Kew KM, Dias S, Cates CJ (2014) Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. Cochrane Database Syst Rev 3: CD010844.
26. Kew KM, Senjukovich A (2014) Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 3: CD010115.
27. Hoonhorst SJ, ten Hacken NH, Vonk JM, Timens W, Hiemstra PS, et al. (2014) Steroid resistance in COPD? Overlap and differential anti-inflammatory effects in smokers and ex-smokers. PloS One 9(2): e87443.
28. Dong YH, Chang CH, Wu FL, Shen LJ, Calverley PM, et al. (2014) Use of inhaled corticosteroids in patients with chronic obstructive pulmonary disease and the risk of tuberculosis and influenza: A systematic review and meta-analysis of randomized controlled trials. Chest Feb 6 [Epub ahead of print].
29. Lee H, Kim J, Tagmazyan K (2013) Treatment of stable chronic obstructive pulmonary disease: the GOLD guidelines. Am Fam Physician 88(10): 655-663.
30. Schünenmann HJ, Woodhead M, Anzueto A, Buist AS, Macnee W, et al. (2012) A guide to guidelines for professional societies and other developers of recommendations. Introduction to integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc 9(5): 215-218.
31. Yawn BP, Akl EA, Qaseem A, Black P, Campos-Outcalt D, et al. (2012) Identifying targed audiences: who are the guidelines for? Article 1 in integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thor Soc 9(5): 219-224.
32. Wilt TJ, Guyatt G, Kunz R, Macnee W, Puhan MA, et al. (2012) Deciding what type of evidence and outcomes to include in guidelines. Article 5 in integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thor Soc 9(5): 243-250.
33. Grimshaw JM, Schünenmann HJ, Burgers JS, Cruz AA, Heffner J, et al. (2012) Disseminating and implementing guidelines. Article 13 in integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thor Soc 9(5): 298-303.
34. Burgers JS, Anzueto A, Black PN, Cruz AA, Fervers B, et al. (2012) Adaptation, evaluation and updating of guidelines. Article 14 in integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc 9(5): 304-310.
35. Parker DR, Eaton CB, Ahern DK, Roberts MB, Rafferty C, et al. (2013) The study design and rationale of the randomized controlled trial: translating COPD guidelines into primary care practice. BMC Fam Pract 6; 14: 56.
36. Institute of Health Information and Statistics of the Czech Republic - UZIS. Available: https://uzis.cz/en/category/tematicke-rady/health-statistics/pneumology-phthisiology Accessed 1 April 2014.
37. Maio S, Baldacci S, Martini F, Cerrai S, Sarno G, et al. (2014) COPD management according to old and new GOLD guidelines: an observational study with Italian general practitioners. Curr Med Res Opin Feb 3 [Epub ahead of print].
38. White P, Thorton H, Pinnock H, Georgopoulou S, Booth HP (2013) Overtreatment of COPD with inhaled corticosteroids - implications for safety and costs: cross-sectional observational study. PLoS One 23; 8(10): e75221.
39. Lucas AE, Smeenk FW, Smeele IJ, van Schayck CP (2008) Overtreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory study. Fam Pract 25(2): 86-91.
40. Roche N, Pribil C, van Ganse E, Serrier P, Housset B, et al. (2014) Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study. BMC Pulm Med 14(1): 56.
41. Ford ES, Mannino DM, Giles WH, Wheaton AG, Liu Y, et al. (2014) Prescription practices for Chronic Obstructive Pulmonary Disease: Findings from the National Ambulatory Medical Care Survey 1999-2010. COPD Feb 25 [Epub ahead of print].
42. Smidth M, Christensen MB, Fenger-Grøn M, Olesen F, Vedsted P (2013) The effect of an active implementation of a disease management programme for chronic obstructive pulmonary disease on healthcare utilization-a clusterrandomised controlled trial. BMC Health Serv Res 13: 385.
43. Valipour A, Koblizek V, Tkacova R, Tudoric N, Zykov K, et al. (2014) Phenotypes of COPD in Central and Eastern Europe (POPE). Available: https://clinicaltrials.gov/ct2/show/NCT02119494?term=COPD+Czech+ republic&rank=2Accessed 8 May 2014.